PharmaTimesNews & Politicsnews

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb

Tuesday, June 2, 2026John PinchingView original

Aragen scales Daretabart to commercial-ready production following rapid 9‑month tech transfer

Read the full article on the original site.